Colombia Cannabis Legalization: Policy Timeline, Medical Framework & Reform

Executive Summary

Colombia's House of Representatives took a historic step in May 2026 by advancing comprehensive cannabis legalization legislation through committee, marking the nation's most serious attempt to end prohibition since medical cannabis was authorized in 2016. The bill, which would establish a regulated adult-use market alongside the existing medical framework, passed the First Committee of the House with majority support and now moves to full floor debate. If enacted, Colombia would become the third Latin American nation after Uruguay and Mexico to legalize recreational cannabis at the federal level, transforming a country that has spent decades battling drug cartels into a potential global leader in legal cannabis production. The legislation would permit adults 18 and older to purchase cannabis from licensed retailers, cultivate up to 20 plants for personal use, and establish a taxation framework directing revenue toward rural development and drug treatment programs. The bill faces significant opposition from conservative lawmakers and the Catholic Church, but proponents argue legalization would undercut illegal markets, generate hundreds of millions in tax revenue, and provide legal economic opportunities for farmers in regions historically dominated by coca cultivation.

Why This Matters

Colombia's move toward legalization carries implications far beyond its borders, potentially reshaping Latin American drug policy, global cannabis supply chains, and the decades-old war on drugs. Colombia is the world's fourth-largest country by population in Latin America with approximately 52 million people, representing a substantial consumer market. More critically, Colombia possesses ideal growing conditions in its Andean highlands and Caribbean coastal regions, with year-round cultivation potential that has already made it a leading exporter of legal medical cannabis flower to markets including Germany, Israel, and Australia. Industry analysts estimate Colombia's legal cannabis market could reach $850 million annually within five years of adult-use legalization, with export potential exceeding $1.2 billion as European and North American markets expand. For Colombian farmers, legalization represents economic transformation. An estimated 120,000 rural families currently participate in illicit cannabis cultivation, according to the Colombian Ministry of Justice, with many more involved in coca production for cocaine manufacturing. Legal cannabis offers a substitute crop with significantly higher margins than coffee or cacao, the traditional legal alternatives promoted by crop substitution programs. The bill includes provisions for smallholder farmer cooperatives to obtain cultivation licenses, potentially channeling income to regions like Cauca, Nariño, and Putumayo that have borne the brunt of drug-related violence. Geopolitically, Colombian legalization would accelerate the collapse of prohibition consensus across Latin America. Uruguay legalized in 2013, Mexico's Supreme Court effectively mandated legalization in 2021 (though implementation remains incomplete), and Argentina decriminalized personal cultivation in 2024. A Colombian legal market would create momentum for Brazil, Chile, and Ecuador to reconsider their own policies, potentially isolating the United States as the primary prohibitionist force in the hemisphere despite state-level reforms.

Background and History

Colombia's relationship with cannabis spans centuries, from indigenous use through colonial prohibition to its emergence as a major illicit producer in the 1970s and eventual pivot toward medical legalization in the 21st century.

Pre-Columbian and Colonial Period (Pre-1500s–1920s)

Cannabis is not native to Colombia, but arrived through multiple pathways beginning in the colonial era. Spanish colonizers introduced hemp cultivation for rope and textile production in the 1500s, though it never achieved the agricultural importance it held in North American colonies. Separate from industrial hemp, psychoactive cannabis varieties arrived through Caribbean trade routes in the 1800s, brought by sailors and merchants from Jamaica and other British colonies where ganja culture had taken root among Indian and African laborers. By the early 1900s, cannabis use was established in Colombia's Caribbean coastal cities, particularly Barranquilla and Santa Marta, where it was consumed recreationally and medicinally by working-class communities. Colombia's first drug prohibition laws emerged in the 1920s under pressure from the United States, which was promoting international narcotics control through the League of Nations. Law 11 of 1920 prohibited importation and sale of cocaine, morphine, and other narcotics, though cannabis was not initially included.

The Santa Marta Gold Era (1960s–1980s)

Colombia emerged as a major cannabis exporter to the United States during the 1960s and 1970s, producing legendary strains like Santa Marta Gold and Colombian Gold that became foundational genetics for modern cannabis breeding. The Sierra Nevada de Santa Marta mountains provided ideal growing conditions, and proximity to Caribbean shipping routes enabled smuggling operations that supplied an estimated 70-80% of U.S. cannabis consumption by the mid-1970s, according to U.S. Drug Enforcement Administration estimates from that period. This era generated substantial wealth in northern Colombia but also attracted violent competition among trafficking organizations. The same smuggling networks that moved cannabis increasingly shifted to cocaine in the late 1970s as profit margins for coca products far exceeded those for marijuana. By the early 1980s, the Medellín and Cali cartels dominated Colombian organized crime, and cannabis cultivation declined as farmers and traffickers pivoted to coca. The United States launched aerial herbicide spraying programs in Colombia beginning in 1978, deploying paraquat and later glyphosate to destroy cannabis and coca crops. These eradication efforts, conducted under Plan Colombia and subsequent bilateral agreements, continued through 2015 and destroyed hundreds of thousands of hectares of cannabis cultivation while generating significant environmental damage and health concerns among rural populations.

Medical Cannabis Legalization (2015–2016)

Colombia's modern cannabis reform began in December 2015 when President Juan Manuel Santos issued Decree 2467, legalizing medical cannabis production and establishing a licensing framework under the Ministry of Health. The decree came amid broader drug policy reforms associated with peace negotiations between the Colombian government and FARC guerrillas, with policymakers seeking alternative development strategies for coca-growing regions. In July 2016, the Colombian Congress passed Law 1787, providing statutory foundation for the medical cannabis program and creating three license categories: cultivation, manufacturing, and distribution. The law established THC limits of 1% for non-psychoactive products and required physician authorization for higher-THC medical formulations. By 2018, Colombia had issued more than 400 cultivation licenses, attracting significant foreign investment from Canadian licensed producers including Canopy Growth, Aurora Cannabis, and Tilray, as well as domestic agricultural conglomerates.

Export Market Development (2017–2024)

Colombia's medical cannabis industry focused heavily on export markets, capitalizing on lower production costs compared to North American and European competitors. Colombian greenhouse cultivation costs averaged $0.15-0.25 per gram of dried flower in 2020, compared to $0.75-1.25 per gram in Canada, according to industry analyses. The country exported its first legal medical cannabis shipment to the United States in 2018, and by 2023 had established export relationships with 15 countries. However, the industry faced significant challenges. Global medical cannabis prices collapsed between 2020 and 2023 as supply outpaced demand, with wholesale flower prices in Germany falling from €8-10 per gram to €2-3 per gram. Many Colombian producers struggled with quality control, regulatory compliance, and access to capital. Several high-profile operations, including Clever Leaves' facility in Pesca and PharmaCielo's operations in Rionegro, underwent restructuring or scaled back production. Despite these challenges, Colombia maintained its position as a leading exporter, shipping approximately 12 metric tons of dried flower and 850 kilograms of cannabis extracts in 2024, according to Ministry of Health export data. The industry employed an estimated 15,000 workers directly and supported thousands more in ancillary services.

Momentum Toward Adult-Use Legalization (2022–2026)

Serious legislative efforts to legalize adult-use cannabis began in 2022 when Senator Gustavo Bolívar introduced comprehensive legalization legislation. Bolívar, a member of the Historic Pact coalition that brought President Gustavo Petro to power in 2022, argued that prohibition had failed to reduce consumption while enriching criminal organizations and criminalizing poor Colombians. President Petro, a former guerrilla and longtime advocate for drug policy reform, endorsed the legalization framework in his 2023 State of the Union address, calling for "a new approach to drugs based on public health, human rights, and economic development rather than militarization and incarceration." The administration submitted its own legalization bill to Congress in September 2023, incorporating elements of Bolívar's proposal while adding provisions for farmer cooperatives and rural development funding. The bill underwent extensive committee hearings throughout 2024 and early 2025, with testimony from medical professionals, law enforcement officials, farmers, and international experts. The First Committee of the House of Representatives, which handles constitutional and legal affairs, approved an amended version of the legislation in May 2026 by a vote of 21-14, sending it to the full House for debate.

Key Players

President Gustavo Petro

President Petro has positioned cannabis legalization as a cornerstone of his broader drug policy reform agenda, which seeks to end Colombia's role as enforcer of U.S.-led prohibition. Elected in 2022 as Colombia's first leftist president, Petro spent decades advocating for alternatives to the war on drugs, arguing that militarized eradication and interdiction have cost Colombia tens of thousands of lives while failing to reduce cocaine production. His administration has proposed replacing forced coca eradication with voluntary crop substitution programs, and views legal cannabis as a viable alternative crop that can generate legitimate income for rural communities. Petro has used international forums, including the United Nations General Assembly, to call for global drug policy reform and an end to prohibition.

Senator Gustavo Bolívar

Senator Bolívar, a television producer turned politician, authored the initial adult-use legalization bill and has served as the primary legislative champion for reform. Bolívar represents the Historic Pact coalition and chairs the Senate's Second Committee, which handles economic and agricultural policy. He has emphasized the economic benefits of legalization, citing projections that a regulated market could generate 75,000 jobs and $200 million in annual tax revenue. Bolívar has also highlighted the racial and class dimensions of cannabis prohibition, noting that Afro-Colombian and indigenous communities face disproportionate arrest rates for cannabis offenses.

Ministry of Justice and Law

The Ministry of Justice, led by Minister Néstor Osuna, has provided technical support for the legalization framework, including drafting regulations for licensing, taxation, and local control provisions. The Ministry conducted a comprehensive review of international legalization models, examining Uruguay's state monopoly system, Canada's provincial distribution frameworks, and various U.S. state approaches. Ministry officials have emphasized that legalization must include robust protections against youth access and impaired driving, as well as mechanisms to prevent corporate consolidation that could exclude smallholder farmers.

Colombian Cannabis Industry Association

The industry association, representing licensed medical cannabis producers, has offered qualified support for adult-use legalization while advocating for provisions that would allow existing medical licensees to enter the recreational market. The association has emphasized that Colombia's established cultivation infrastructure and export expertise position the country to become a global leader in legal cannabis production. However, some medical producers have expressed concern that a domestic recreational market could divert supply from higher-margin export contracts.

Catholic Church and Conservative Opposition

The Colombian Conference of Catholic Bishops has emerged as the most vocal opponent of legalization, arguing that cannabis use harms youth development and that legalization would send a message of social acceptance. Archbishop Luis José Rueda, president of the bishops' conference, stated in a March 2026 pastoral letter that "the legalization of marijuana represents a grave moral error that prioritizes tax revenue over the wellbeing of our young people." Conservative political parties, including the Democratic Center founded by former President Álvaro Uribe, have echoed these concerns and argued that legalization would complicate Colombia's relationship with the United States.

Rural Farmer Organizations

Organizations representing small-scale farmers, including the National Coordinator of Coca, Marijuana, and Poppy Growers (COCCAM), have advocated for legalization provisions that prioritize access for rural communities over large corporations. These groups have pushed for licensing preferences for farmers in regions affected by armed conflict, technical assistance programs, and limits on vertical integration that would prevent large companies from controlling cultivation, processing, and retail. COCCAM has warned that without such protections, legalization could replicate patterns from the medical cannabis industry, where multinational corporations captured most of the economic value while rural communities remained marginalized.

Legal and Regulatory Framework

The proposed legalization bill would amend Colombia's National Narcotics Statute (Law 30 of 1986) and create a comprehensive regulatory system overseen by multiple government agencies. The legislation establishes the National Cannabis Regulatory Agency (ANCA), an independent body within the Ministry of Justice responsible for licensing, compliance monitoring, and enforcement. ANCA would operate similarly to Canada's Cannabis Act framework, with authority to issue and revoke licenses, conduct inspections, and impose administrative penalties for violations. The bill creates five license categories: cultivation, manufacturing, testing, distribution, and retail. Cultivation licenses would be subdivided into micro-cultivation (up to 200 plants), small-scale (201-2,000 plants), and commercial (over 2,000 plants) tiers, with the micro and small-scale categories reserved exclusively for farmer cooperatives and individual cultivators for the first five years of implementation. This tiered approach draws from lessons learned in U.S. states like Illinois and Massachusetts, where social equity provisions have attempted to ensure diverse market participation. Personal possession limits would allow adults 18 and older to possess up to 20 grams of dried flower in public and cultivate up to 20 plants at a private residence. These limits align with those established in Mexico's legalization framework and exceed the more restrictive limits in Uruguay, which caps personal possession at 40 grams per month through registered pharmacy purchases. The bill establishes a 19% excise tax on retail cannabis sales, in addition to Colombia's standard 19% value-added tax (VAT). Revenue from the cannabis excise tax would be allocated through a dedicated fund: 40% to rural development programs in conflict-affected regions, 30% to drug treatment and prevention services, 20% to municipal governments where sales occur, and 10% to regulatory administration. This revenue allocation model resembles approaches in U.S. states like Colorado and California, which earmark cannabis tax revenue for specific public purposes. Product regulations would require testing for potency, pesticides, heavy metals, and microbial contamination, with testing conducted by independent laboratories licensed by ANCA. The bill prohibits certain additives, including vitamin E acetate (linked to vaping injuries) and synthetic cannabinoids. Packaging must be child-resistant, opaque, and include health warnings covering at least 30% of the principal display panel. These standards largely mirror those established under Canada's Cannabis Act and regulations. Marketing and advertising restrictions would prohibit television and radio advertising, sponsorship of sporting events, and any marketing that could appeal to minors. Retail stores could not be located within 200 meters of schools, and municipalities would have authority to impose additional zoning restrictions or ban retail sales entirely through local referendum. This local control provision addresses concerns from conservative municipalities while allowing reform-friendly cities to implement sales. The bill includes expungement provisions requiring automatic clearance of criminal records for cannabis possession offenses below the new legal limits, and establishes a process for individuals currently incarcerated for such offenses to petition for resentencing. An estimated 8,000-12,000 Colombians are currently serving sentences for cannabis-related offenses, according to Ministry of Justice data, though many of these cases involve trafficking quantities that would remain illegal under the new framework.

Market and Business Implications

Legalization would create a domestic market projected to reach 50-80 metric tons of annual consumption while transforming Colombia's position in global cannabis trade. Market research firms estimate Colombia's adult-use cannabis market could generate $400-600 million in annual retail sales within three years of legalization, based on consumption patterns in comparable markets and Colombia's population demographics. With approximately 3.5 million current cannabis consumers, according to the most recent National Survey on Psychoactive Substance Use conducted in 2023, and an estimated 1-2 million additional consumers who might enter the legal market, Colombia would represent a mid-sized market comparable to Canada or Germany. For existing medical cannabis producers, legalization presents both opportunities and challenges. Companies with established cultivation infrastructure could quickly pivot to serve the domestic recreational market, but would face new competition from small-scale cultivators and farmer cooperatives that would receive licensing preferences. Several major producers, including Khiron Life Sciences and Clever Leaves, have indicated they would seek dual licensing for medical and recreational production, while maintaining focus on higher-margin international medical exports. The craft cannabis segment could emerge as a significant market force, particularly if micro-cultivation licenses enable small producers to differentiate based on terroir, organic certification, and heritage genetics. Colombia's diverse microclimates and legacy of landrace strains like Punto Rojo, Corinto, and Limon Verde could support premium products commanding higher prices, similar to the craft cannabis markets that have developed in California and Oregon. Foreign investment patterns would likely shift substantially. Canadian licensed producers, which invested heavily in Colombian medical cannabis between 2017 and 2020, have largely retreated due to oversupply and financial challenges in their home market. However, U.S. multi-state operators (MSOs) could view Colombia as an attractive expansion opportunity, particularly if U.S. federal legalization enables cross-border investment. Companies like Curaleaf, Green Thumb Industries, and Trulieve have expressed interest in international markets, and Colombia's combination of low production costs and domestic market potential could attract significant capital. The bill's taxation framework would generate substantial government revenue, though projections vary widely. Conservative estimates from the Ministry of Finance project $150-200 million in annual excise tax revenue once the market matures, while optimistic scenarios from industry advocates suggest $300-400 million. For context, Colombia's coffee sector generates approximately $2.5 billion in annual export revenue, suggesting legal cannabis could become a significant but not dominant agricultural commodity. Employment impacts would extend beyond direct cultivation and retail jobs. Ancillary businesses including testing laboratories, security services, packaging manufacturers, and compliance consultants would create thousands of additional positions. The Colombian Cannabis Industry Association projects total employment of 60,000-75,000 workers within five years of legalization, concentrated in regions including Antioquia, Cundinamarca, and the Caribbean coast where cultivation infrastructure already exists. Banking and financial services remain a significant challenge. Colombian banks have been reluctant to serve medical cannabis businesses due to concerns about U.S. sanctions and correspondent banking relationships, forcing many operators to conduct transactions in cash or through limited domestic banking channels. Adult-use legalization could exacerbate these challenges unless Colombia's financial regulators provide clear guidance and the U.S. passes legislation like the SAFER Banking Act to protect financial institutions serving legal cannabis businesses.

What Experts Say

Policy analysts, public health researchers, and economists have offered diverse perspectives on Colombia's legalization proposal, with broad agreement that implementation details will determine success or failure. Alejandro Gaviria, former Minister of Health and current rector of Universidad de los Andes, has supported legalization while emphasizing the need for robust public health measures. In testimony before the House First Committee in March 2026, Gaviria stated that "prohibition has failed to prevent cannabis use while creating significant social costs through criminalization and incarceration. However, legalization without adequate investment in prevention, treatment, and research would be equally irresponsible." Gaviria has advocated for dedicating at least 30% of cannabis tax revenue to evidence-based drug education and treatment programs. Daniel Mejía, an economist at Universidad de los Andes who has studied drug policy extensively, has emphasized the potential for legalization to reduce violence and corruption associated with illegal markets. According to Mejía's research, published in the journal World Development in 2024, illegal cannabis markets in Colombia generate an estimated $800 million-1.2 billion annually, with profits funding armed groups and criminal organizations. Mejía has argued that "a well-regulated legal market could capture 60-70% of this illicit trade within three years, significantly reducing the resources available to violent actors." International observers have noted Colombia's potential to influence regional drug policy. John Walsh, director for drug policy and the Andes at the Washington Office on Latin America, said in a May 2026 analysis that "Colombian legalization would represent a definitive break with the prohibitionist consensus that has dominated Latin American drug policy for decades. Combined with reforms in Uruguay, Mexico, and Argentina, it would create momentum for a fundamentally different approach based on regulation rather than criminalization." Public health researchers have raised concerns about youth access and impaired driving. Dr. Juliana Mejía of the Colombian National Institute of Health has pointed to data from U.S. states showing increases in cannabis-related emergency department visits following legalization, particularly for high-potency edibles and concentrates. She has recommended that Colombia's regulations include strict potency limits for edible products and mandatory serving-size standardization to reduce accidental overconsumption. Agricultural economists have debated whether legalization would effectively compete with coca cultivation. Francisco Thoumi, a leading expert on Colombian drug economies who passed away in 2017, argued in his final work that coca's profitability and the infrastructure supporting cocaine production would make it difficult for legal cannabis to serve as a complete substitute. However, more recent analyses suggest that in regions where armed group control has weakened, legal cannabis could provide viable income for farmers seeking to exit illicit markets.

What's Next

The legalization bill faces several critical steps before becoming law, with implementation likely extending into 2027 or 2028 even if legislative approval proceeds smoothly. The full House of Representatives is expected to debate the bill in June or July 2026, with a floor vote possible before the legislature's mid-year recess in late July. House passage would require a simple majority of the 172-member body. The Historic Pact coalition and allied parties control approximately 85 seats, meaning the bill would need support from moderate members of opposition parties to pass. Proponents are targeting members from rural districts where legal cannabis cultivation could provide economic benefits. If the House approves the bill, it would move to the Senate, where the legislative process would begin anew with committee hearings and floor debate. The Senate's 108 members include a similar coalition breakdown to the House, but several key swing votes remain uncommitted. Senate consideration would likely extend into late 2026 or early 2027. Constitutional challenges are possible even if the bill passes both chambers. Conservative legal scholars have argued that legalization could violate Colombia's international treaty obligations under the 1961 Single Convention on Narcotic Drugs and the 1988 Convention Against Illicit Traffic in Narcotic Drugs. However, legal experts note that Uruguay and Canada have legalized cannabis while remaining parties to these treaties, and that the conventions allow for flexibility in domestic implementation. Colombia's Constitutional Court would have final authority to resolve any constitutional questions. Implementation would require extensive regulatory development even after legislative approval. The National Cannabis Regulatory Agency would need to establish detailed licensing procedures, product standards, testing protocols, and enforcement mechanisms. Based on timelines in other jurisdictions, this regulatory development typically requires 12-18 months. Uruguay took nearly two years to implement its 2013 legalization law, while Canada required approximately 18 months between passage of the Cannabis Act in June 2018 and the opening of legal retail stores in October 2018. Local governments would need to make decisions about whether to allow retail sales and where to permit cannabis businesses. Colombia's 1,103 municipalities would each have authority to regulate or prohibit sales within their jurisdictions, creating a patchwork of local policies similar to those in U.S. states with local control provisions. Major cities including Bogotá, Medellín, and Cali would likely permit sales, while conservative rural municipalities might opt out. International implications could unfold over several years. If Colombia successfully implements legalization, it could accelerate reform efforts in Brazil, where several legalization bills are pending in Congress, and in Chile, where President Gabriel Boric has expressed support for cannabis policy reform. Regional legalization could create pressure for international treaty reform or reinterpretation, potentially through the United Nations Commission on Narcotic Drugs. The U.S. response remains uncertain. The Biden administration has maintained opposition to international cannabis legalization while tolerating state-level reforms domestically. However, if U.S. federal legalization advances through legislation like the Cannabis Administration and Opportunity Act, U.S. objections to Colombian legalization would lose credibility. Conversely, a future U.S. administration could threaten trade sanctions or other consequences, though such measures would likely prove counterproductive and face resistance from U.S. businesses seeking access to Colombian cannabis markets. Market development would occur in phases. Initial implementation would likely focus on establishing cultivation licensing and retail infrastructure in major urban centers, with expansion to smaller cities and rural areas occurring over subsequent years. Export markets could open if Colombia negotiates bilateral agreements with countries that have legalized cannabis, potentially including Canada, Germany, and eventually the United States if federal prohibition ends.

Further Reading

• Law 30 of 1986 (National Narcotics Statute) - Full text at https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=2774
• Decree 2467 of 2015 (Medical Cannabis Legalization) - https://www.minsalud.gov.co/Normatividad_Nuevo/Decreto%202467%20de%202015.pdf
• Law 1787 of 2016 (Medical Cannabis Statutory Framework) - https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=76434
• Ministry of Justice Cannabis Policy Reports - https://www.minjusticia.gov.co/programas-co/politica-de-drogas
• Colombian National Survey on Psychoactive Substance Use (2023) - https://www.minjusticia.gov.co/programas-co/ODC
• 1961 Single Convention on Narcotic Drugs - Full text at https://www.unodc.org/unodc/en/treaties/single-convention.html
• Cannabis Act (Canada) - Comparative framework at https://laws-lois.justice.gc.ca/eng/acts/c-24.5/
• Washington Office on Latin America Drug Policy Analysis - https://www.wola.org/program/drug-policy/
• Universidad de los Andes Drug Policy Research - https://economia.uniandes.edu.co/investigaciones-y-publicaciones/revista-desarrollo-y-sociedad
• Colombian Cannabis Industry Association - https://www.asocolcanna.org/